Expression and activation of the farnesoid X receptor in the vasculature

David Bishop-Bailey1, Desmond T Walsh, Timothy D Warner

  • 1Cardiac, Vascular, and Inflammation Research, William Harvey Research Institute, Barts and the London, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom. d.bishop-bailey@qmul.ac.uk

Insights

The farnesoid X receptor (FXR) is found in human vasculature and promotes apoptosis in vascular smooth muscle cells. This nuclear receptor may offer a new therapeutic target for cardiovascular and metabolic diseases.

Area of Science:

  • Molecular Biology
  • Cardiovascular Science
  • Endocrinology

Background:

  • The farnesoid X receptor (FXR), a nuclear hormone receptor, plays roles in cholesterol and bile acid metabolism.
  • FXR ligands are being investigated for cardiovascular disease applications.
  • FXR's presence and function in the vasculature were previously not well-defined.

Purpose of the Study:

  • To investigate the expression and function of FXR in human cardiovascular tissues.
  • To determine the effect of FXR activation on vascular smooth muscle cells.
  • To explore FXR as a potential therapeutic target for vascular and metabolic disorders.

Main Methods:

  • Analysis of FXR expression in a human cardiovascular tissue array.
  • In vitro studies using rat and human vascular smooth muscle cells.
  • Treatment of cells with FXR ligands and assessment of apoptosis and target gene mRNA levels.

Main Results:

  • FXR is expressed in various human tissues, with high levels detected in the vasculature, liver, small intestine, and kidney.
  • FXR is present in vascular smooth muscle cells, and FXR activators induce apoptosis in these cells.
  • FXR activation leads to increased mRNA expression of phospholipid transfer protein and small heterodimer partner.

Conclusions:

  • FXR is a functional protein within the vasculature.
  • FXR activation induces vascular smooth muscle cell apoptosis, suggesting a role in vascular homeostasis.
  • FXR represents a potential therapeutic target for proliferative and dyslipidaemic vascular diseases.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...